Posts in category: Uncategorized

Sodium glucose co-transporter-2 (SGLT2) inhibitors do not lead to lower 28-day all-cause mortality compared with usual care or placebo in patients hospitalized with COVID-19, according to late breaking research presented in a Hot Line session August 28 at ESC Congress 2023.

Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces cardiac events compared to placebo in patients at risk of renal injury undergoing coronary angiography for acute coronary syndrome, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

Active screening of patients with type 2 diabetes or chronic obstructive pulmonary disease (COPD) more than doubles new diagnoses of cardiovascular disease compared with usual care, according to late breaking research presented in a Hot Line session at ESC Congress 2023.

A pragmatic natriuresis guided diuretic approach in patients with acute heart failure significantly increases 24-hour natriuresis without impacting all-cause mortality or heart failure rehospitalization, according to late breaking research presented in a Hot Line session at ESC Congress 2023.

A study published in the journal Foods provides an overview of research on minimally processed vegetables (MPVs), with a specific focus on the Brazilian market.

New research led by Nansi Boghossian, associate professor of epidemiology, has investigated the relationship between sickle cell disease and severe maternal morbidity (i.e., adverse outcomes such as heart failure, blood transfusions, and hysterectomy after delivery). In research published in JAMA Pediatrics, the authors found that sickle cell disease was an important contributor to racial disparities in adverse maternal health outcomes.

By SHARON ZULU

TRANSPARENCY International Zambia (TI-Z) is happy with the nullification of large-scale copper mining in the Lower Zambezi National Park by the Zambia Environmental Management Agency (ZEMA).

ZEMA has cancelled the decision letter issued in 2021 pertaining to the large-scale mining project by Mwembeshi Resource Limited in the Lower Zambezi National Park in Luangwa.

TI-Z executive director, Maurice Nyambe says, Mwembeshi Resource Limited had failed to comply with specific conditions before commencing its large-scale mining in the national park and that it was pleasing that ZEMA was holding companies accountable to environmental regulations.

Mr Nyambe said TI-Z had welcomed ZEMA’s decision considering that, even after Zambezi Resource Limited was found in violation of the decision letter, ZEMA did halt and suspend the mining project through a compliance order.

He said the action by ZEMA had revealed that the mining project had no intentions to honour the commitments stated in its environmental impact assessment.

Mr Nyambe said in view of the development, TI-Z was imploring ZEMA to enhance the monitoring of projects to ensure that mining projects complied with the law and commitments in respective environmental impact assessments reports and decision letters.

“ZEMA’s letter outlining the conditions breached by the mine shows that, the mine was not operating in good faith and in compliance with stipulated standards”, Mr Nyambe said.

[/ihc-hide-content

Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking research presented in a Hot Line session August 28 at ESC Congress 2023.

A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George’s, University of London. Results have been published in NEJM Evidence.